Skip to main content

Evaluation of Gallbladder Adenocarcinoma by Next Generation Sequencing Reveals Frequent Actionable Genomic Abnormalities and New Routes to Targeted Therapies

Publication ,  Conference
Tarasen, AJ; Al-Rohil, RN; Wang, K; Rand, JV; Jones, DM; Lee, HJ; Sheehan, CE; Otto, GA; Palmer, G; Ali, SM; Morosini, D; Miller, VA ...
Published in: LABORATORY INVESTIGATION
February 1, 2014

Duke Scholars

Published In

LABORATORY INVESTIGATION

EISSN

1530-0307

ISSN

0023-6837

Publication Date

February 1, 2014

Volume

94

Start / End Page

205A / 206A

Location

San Diego, CA

Publisher

NATURE PUBLISHING GROUP

Conference Name

103rd Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP)

Related Subject Headings

  • Pathology
  • 3202 Clinical sciences
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Tarasen, A. J., Al-Rohil, R. N., Wang, K., Rand, J. V., Jones, D. M., Lee, H. J., … Ross, J. S. (2014). Evaluation of Gallbladder Adenocarcinoma by Next Generation Sequencing Reveals Frequent Actionable Genomic Abnormalities and New Routes to Targeted Therapies. In LABORATORY INVESTIGATION (Vol. 94, pp. 205A-206A). San Diego, CA: NATURE PUBLISHING GROUP.
Tarasen, A. J., R. N. Al-Rohil, K. Wang, J. V. Rand, D. M. Jones, H. J. Lee, C. E. Sheehan, et al. “Evaluation of Gallbladder Adenocarcinoma by Next Generation Sequencing Reveals Frequent Actionable Genomic Abnormalities and New Routes to Targeted Therapies.” In LABORATORY INVESTIGATION, 94:205A-206A. NATURE PUBLISHING GROUP, 2014.
Tarasen AJ, Al-Rohil RN, Wang K, Rand JV, Jones DM, Lee HJ, et al. Evaluation of Gallbladder Adenocarcinoma by Next Generation Sequencing Reveals Frequent Actionable Genomic Abnormalities and New Routes to Targeted Therapies. In: LABORATORY INVESTIGATION. NATURE PUBLISHING GROUP; 2014. p. 205A-206A.
Tarasen, A. J., et al. “Evaluation of Gallbladder Adenocarcinoma by Next Generation Sequencing Reveals Frequent Actionable Genomic Abnormalities and New Routes to Targeted Therapies.” LABORATORY INVESTIGATION, vol. 94, NATURE PUBLISHING GROUP, 2014, pp. 205A-206A.
Tarasen AJ, Al-Rohil RN, Wang K, Rand JV, Jones DM, Lee HJ, Sheehan CE, Otto GA, Palmer G, Ali SM, Morosini D, Miller VA, Stephens PJ, Ross JS. Evaluation of Gallbladder Adenocarcinoma by Next Generation Sequencing Reveals Frequent Actionable Genomic Abnormalities and New Routes to Targeted Therapies. LABORATORY INVESTIGATION. NATURE PUBLISHING GROUP; 2014. p. 205A-206A.

Published In

LABORATORY INVESTIGATION

EISSN

1530-0307

ISSN

0023-6837

Publication Date

February 1, 2014

Volume

94

Start / End Page

205A / 206A

Location

San Diego, CA

Publisher

NATURE PUBLISHING GROUP

Conference Name

103rd Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP)

Related Subject Headings

  • Pathology
  • 3202 Clinical sciences
  • 1103 Clinical Sciences